Prelude Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$31.4K Buy
2023
Q3
Sell
2023
Q2
$59.5K Buy
2023
Q1
$57.5K Buy
2018
Q2
Sell
2018
Q1
$23K Buy
2017
Q4
Sell
2017
Q3
$5K Buy
2017
Q2
Sell
2017
Q1
$97K Buy
2016
Q4
$2K Sell
2016
Q3
$4K Buy